| Ensembl ID |
ENSG00000006744 |
Gene ID |
60528 |
Accession |
14198 |
| Gene Symbol |
ELAC2 |
Alias |
|
Full Name |
|
| Position |
17 : 12991612 - 13018065 |
Length |
26454 bases |
Strand |
Minus strand |
| Status |
Confidence |
Main interacting RNAs | tRNA | RBP type |
Canonical_RBPs |
| Summary |
|
ENSG00000006744 Expression In 33 Tumors
| Ensembl ID |
Gene symbol |
Log2 Foldchange |
Pvaue |
Cancer |
| ENSG00000006744 |
ELAC2 |
0.62 |
1.39e-13 |
KIRP |
| ENSG00000006744 |
ELAC2 |
0.59 |
7.96e-12 |
UCEC |
| Ensembl ID |
Gene symbol |
Cancer types |
Pubmed ID |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
10986046 |
| ENSG00000006744 |
ELAC2 |
prostate tumors |
11175773 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
11175785 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
11254448 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
11254449 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
11431329 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
11507049 |
| ENSG00000006744 |
ELAC2 |
hereditary prostate cancer |
11522646 |
| ENSG00000006744 |
ELAC2 |
Prostate cancer |
11673416 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
11751379 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
12021166 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
12373607 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
12384782 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
12522685 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
12552947 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
12569551 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
12711671 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
12783937 |
| ENSG00000006744 |
ELAC2 |
prostatic cancer |
12949798 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
14504198 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
14601029 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
14612911 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
14625808 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
14695991 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
14719475 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
14729485 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
14749351 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
15358515 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
15368467 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
15593091 |
| ENSG00000006744 |
ELAC2 |
hereditary prostate cancer |
15714208 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
15824169 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
15863270 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
15892892 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
16114055 |
| ENSG00000006744 |
ELAC2 |
familial prostate cancer |
16267836 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
16636667 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
16648113 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
16869093 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
16986064 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
17134822 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
18375959 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
18767027 |
| ENSG00000006744 |
ELAC2 |
prostate-cancer |
19555350 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
19933153 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
20086112 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
20231859 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
20819227 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
21475371 |
| ENSG00000006744 |
ELAC2 |
benign tumor |
21627373 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
21781332 |
| ENSG00000006744 |
ELAC2 |
pancreatic cancer |
22406361 |
| ENSG00000006744 |
ELAC2 |
pancreatic cancer |
22811080 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
23141781 |
| ENSG00000006744 |
ELAC2 |
Prostate Cancer |
24052700 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
24864115 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
26251261 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
26501111 |
| ENSG00000006744 |
ELAC2 |
Prostate cancer |
26805042 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
27318894 |
| ENSG00000006744 |
ELAC2 |
ovarian cancer |
27323405 |
| ENSG00000006744 |
ELAC2 |
tumor |
28529640 |
| ENSG00000006744 |
ELAC2 |
pancreatic cancer |
30953499 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
31045291 |
| ENSG00000006744 |
ELAC2 |
Prostate Cancer |
31321101 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
31452838 |
| ENSG00000006744 |
ELAC2 |
prostate cancer |
9858326 |
| Ensembl ID |
Gene symbol |
Disease/phenotype |
Mutation type |
Mutated / Total samples |
Literature |
| Ensembl ID |
Gene symbol |
Cancer |
P-value |
Which worse |
show |
| ENSG00000006744 |
ELAC2 |
UVM |
0.0026 |
high |
|
| ENSG00000006744 |
ELAC2 |
PAAD |
0.0022 |
low |
|
| ENSG00000006744 |
ELAC2 |
HNSC |
0.024 |
low |
|
| ENSG00000006744 |
ELAC2 |
KIRP |
0.0017 |
low |
|
| ENSG00000006744 |
ELAC2 |
BRCA |
0.018 |
high |
|
| ENSG00000006744 |
ELAC2 |
COAD |
0.04 |
high |
|
| ENSG00000006744 |
ELAC2 |
UCS |
0.021 |
high |
|
| ENSG00000006744 |
ELAC2 |
ESCA |
0.012 |
low |
|
| ENSG00000006744 |
ELAC2 |
KIRC |
0.00014 |
high |
|
| ENSG00000006744 |
ELAC2 |
BLCA |
0.014 |
high |
|
| ENSG00000006744 |
ELAC2 |
SKCM |
0.0032 |
high |
|
| Ensembl ID |
Gene symbol |
Cancer |
CNV type |
-log10(q-value) |
G-score |
average amplitude |
frequency |
| ENSG00000006744 |
ELAC2 |
UCS |
Del |
0.690854 |
0.201064 |
0.603372 |
0.767857 |
| ENSG00000006744 |
ELAC2 |
SARC |
Amp |
15.212684 |
0.762119 |
1.090003 |
0.389105 |
| ENSG00000006744 |
ELAC2 |
LIHC |
Del |
1.538564 |
0.079297 |
0.650688 |
0.559459 |
| ENSG00000006744 |
ELAC2 |
BLCA |
Del |
1.072691 |
0.083852 |
0.481809 |
0.514706 |
| ENSG00000006744 |
ELAC2 |
BRCA |
Del |
1.086012 |
0.067064 |
0.496325 |
0.591667 |
| ENSG00000006744 |
ELAC2 |
STAD |
Del |
1.304408 |
0.069476 |
0.424519 |
0.410431 |
| ENSG00000006744 |
ELAC2 |
UCEC |
Del |
2.274967 |
0.066084 |
0.615722 |
0.256030 |
| ENSG00000006744 |
ELAC2 |
OV |
Del |
0.716407 |
0.174458 |
0.658958 |
0.844560 |